Unrestricted Access to the Intravenous Tylenol Is Associated with Shorter Length of Stay in the Retrospective Cohort of Patients Treated for the Maxillofacial Trauma in a Level 1 Trauma Center

We observed decreased length of stay in thoracic surgery patients treated with non-opioid multimodal analgesia (NOMA). Whether unrestricted access to the intravenous tylenol (a non-opioid analgesic) which was part of NOMA, affects hospital course and length of stay (LOS) of the maxillofacial trauma patients, who are less likely to take oral tylenol is unknown.

Source: Journal of the American College of Surgeons - October 22, 2021 Category: Surgery Authors: Mindaugas Pranevicius, Afshin Parsikia, Howard Stupak, Jody M. Kaban, Benn Lieberman, Thomas Whitmer, Denise Sullivan, Kari Cleland, John McNelis, Leonard Golden Tags: Plastic and Maxillofacial Surgery Source Type: research